Friday, June 3, 2022

Kintara Gets Nasdaq Extension

San Diego-based biopharmaceuticals firm Kintara reported this morning that it has received a notification from The Nasdaq Stock Market, informing the company that it has been granted a 180-day extension to regain compliance with the Nasdaq's minimum bid price requirement. The company said it now has until November 28, 2022 to meet the requirement. The company first received a warning for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days on December 3rd and had been given until June 1st to regain compliance. Kintara's stock price was hovering around 18 cents per share on Friday morning.